ARCHIVES

Senate Committee Schedules Hearing for FDA Acting Commissioner von Eschenbach.

This article is from The Cancer Letter archive.

Vol. 32 No. 29 | July 28, 2006

Download PDF Visit The Full Archive

Related Articles

Itri Pays Fine, Agrees Not to Serve As Company Officer for Five Years

April 25, 2014

Tobacco Money Placed In Non-Profit Run By Henschke, Weill Cornell Officials.

March 28, 2008

Piperacillin/Tazobactam Valuable Empiric Therapy For Febrile Neutropenia

October 31, 2003

Senate Kills Plan to Increase Tax On Higher Tar, Nicotine Cigarettes

August 13, 1976

New Phase III Follow-Up Data of Yervoy Trial Shows 19 Percent Survival at Four Years

October 26, 2012

Women Who Concieve Using Fertility Drugs Have a Higher Risk Of Breast Cancer Than Non-Users

July 27, 2012